VanEck Associates
GMED icon

VanEck Associates’s Globus Medical GMED Stock Holding History

VanEck Associates’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.16M Buy
103,235
+1,839
+2% +$156K 0.01% 690
2026
Q1 		$8.74M Buy
101,396
+580
+0.6% +$52.1K 0.01% 627
2025
Q4 		$8.8M Buy
100,816
+86,354
+597% +$6.55M 0.01% 596
2025
Q3 		$828K Buy
14,462
+11,176
+340% +$644K ﹤0.01% 1114
2025
Q2 		$194K Buy
3,286
+148
+5% +$9.56K ﹤0.01% 1251
2025
Q1 		$230K Buy
3,138
+204
+7% +$16.9K ﹤0.01% 1226
2024
Q4 		$243K Sell
2,934
-59,571
-95% -$4.7M ﹤0.01% 1210
2024
Q3 		$4.62M Buy
62,505
+16,583
+36% +$1.17M 0.01% 675
2024
Q2 		$3.15M Buy
45,922
+183
+0.4% +$10.9K ﹤0.01% 745
2024
Q1 		$2.45M Buy
45,739
+11,359
+33% +$611K ﹤0.01% 802
2023
Q4 		$1.83M Buy
34,380
+15,552
+83% +$758K ﹤0.01% 821
2023
Q3 		$935K Buy
18,828
+5,467
+41% +$306K ﹤0.01% 914
2023
Q2 		$796K Buy
13,361
+1,453
+12% +$82.8K ﹤0.01% 919
2023
Q1 		$674K Buy
11,908
+7,277
+157% +$467K ﹤0.01% 932
2022
Q4 		$344K Buy
4,631
+1,732
+60% +$118K ﹤0.01% 987
2022
Q3 		$173K Buy
2,899
+261
+10% +$15.7K ﹤0.01% 1057
2022
Q2 		$148K Buy
2,638
+645
+32% +$42.4K ﹤0.01% 1135
2022
Q1 		$147K Sell
1,993
-14,363
-88% -$998K ﹤0.01% 1159
2021
Q4 		$1.18M Buy
16,356
+2,485
+18% +$180K ﹤0.01% 817
2021
Q3 		$1.06M Buy
13,871
+12,917
+1,354% +$1.04M ﹤0.01% 798
2021
Q2 		$74K Buy
954
+548
+135% +$39K ﹤0.01% 1141
2021
Q1 		$25K Buy
+406
New +$25.7K ﹤0.01% 1163

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

VanEck Associates's GMED Position: Q2 2026 in Review

VanEck Associates increased its Globus Medical (GMED) stake by 1.8% in Q2 2026, buying an estimated $156K and bringing the position to 103,235 shares worth $8.16M. The position accounts for 0.01% of the portfolio, ranked #690.

VanEck Associates first reported a position in GMED in Q1 2021 and has held it in 22 quarters since. The position peaked at $8.8M in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • VanEck Associates held 103,235 shares of Globus Medical worth $8.16M as of Q2 2026.
  • VanEck Associates bought 1,839 Globus Medical shares in Q2 2026, an estimated $156K.
  • Globus Medical made up 0.01% of VanEck Associates's portfolio in Q2 2026, its #690 holding.
  • VanEck Associates first reported a position in Globus Medical in Q1 2021 and has held it in 22 quarters since.
  • VanEck Associates's Globus Medical position peaked at $8.8M in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.